1 In Vitro Diagnostic use (IVD): only in the countries specified on the title page of the instructions for use. In all other countries, this product is for Research Use Only (RUO).
2 In people of African descent, the percentage of SMA patients with a homozygous exon 7 deletion may be lower (Labrum et al. 2007). This assay does not detect other causes of SMA such as pathogenic point mutations.
Spinal muscular atrophy (SMA) is a severe, recessive, neuromuscular disease for which treatment options have recently become available. SMA is caused by a complete absence of functional copies of the SMN1
gene. In most populations, homozygous absence of the exon 7 DNA sequence of the SMN1
gene is observed in 95-98% of SMA patients. In most remaining cases, point mutations or partial deletions in the SMN1
gene are the cause of disease. For more information see Appendix 1: Background Information in the instructions for use.
In the SALSA MC002 SMA Newborn Screen PCR, amplification of exon 7 of the SMN1
gene and the closely related SMN2
gene is performed, followed by fluorescent probe binding to the amplicons and generation of a melt curve (Figure 1, Strunk et al. 2019). Fluorescence is only measured during melt curve generation.
Absence of the SMN1
-specific melt peak at 63°C is indicative of the absence of the SMN1
exon 7 DNA sequence. The presence of an SMN1
(63°C) and/or SMN2
(56°C) specific melt peak and an absent or low signal for the Q (quantity)-fragment specific melt peak (49°C) indicates successful assay performance and the use of sufficient sample DNA. The assay uses a crude DNA extract prepared from a 1.5 mm or 3.2 mm punch of a DBS card or purified DNA from peripheral blood. More information on the assay can be found in Appendix 2: SALSA MC002 SMA Newborn Screen in the instructions for use.
Figure 1. Summary of assay steps. (A) The exon 7 regions of SMN1 and SMN2 are amplified with a single set of primers, with one primer in excess. (B) A fluorescently-labelled probe binds to the amplicons. (C) The resulting melt curve indicates SMN1 and SMN2 sequence presence and DNA quantity.
Download our demosheet
for more information, read more about newborn screening for SMA
on our website, or download a brochure about newborn screening for SMA